The first meeting of the Psoriasis Professional Committee of the 15th Chinese Society of Dermatology and Venerology in 2021 was successfully held in Hefei
Source：Institute of Dermatology, Anhui Medical University Date：2021/03/23 Browse：2167 second
In order to continue to promote the development of psoriasis diagnosis and treatment and basic research in China, to promote the implementation of the Chinese Psoriasis Surveillance Project (GPA), the 15th Chinese Medical Association Skin The 2021 first working meeting of the Psoriasis Professional Committee of the Venereology Branch was successfully held in Hefei, Anhui on the morning of March 21, 2021. This meeting was hosted by the Psoriasis Committee of the Dermatology and Venereology Branch of the Chinese Medical Association, Anhui Medical University Dermatology Organized by the Institute of Disease Research, more than 40 members of the psoriasis group participated in the offline meeting, the director of the Psoriasis Research Center branch, the director of the psoriasis special disease clinic, the member of the Chinese GPA committee, and the dermatology branch of the national provincial medical association. Member of the Etiology Group and editorial board member of the "Guidelines for the Diagnosis and Treatment of Psoriasis in China", "Guidelines for the Diagnosis and Treatment of Psoriasis in Children in China", "Interpretation of Psoriasis", and "Guidelines for the Treatment of Psoriasis in China with Methotrexate" More people attended the meeting online.
meeting venue
This conference was presided over by Professor Zhang Chunlei, Vice Chairman of the Psoriasis Professional Committee of the Chinese Medical Association Dermatovenereology Branch, and the Chinese Medical Association Dermatovenereology Branch Psoriasis Professor Zhang Xuejun, the chairman of the professional committee, first gave a welcome speech. The chairman of the branch, Professor Lu Qianjin and the deputy chairman, Professor Zhang Furen, expressed their heartfelt gratitude for the support and care of the work of the psoriasis committee, and for this offline and online participation. The members of the meeting expressed a warm welcome. Next, Professor Zhang Xuejun reported on the 2020 work of the Psoriasis Professional Committee of the Chinese Medical Association Dermatovenereology Branch, and introduced the work plan for 2021; In 2020, the Psoriasis Professional Committee did the following aspects Main tasks: 1. Established a remote free consultation platform, carried out remote free online diagnosis and treatment for nearly 10,000 psoriasis patients nationwide during the worst period of the epidemic; 2. Carried out a series of 32 GPA online activities and established a GPA flow adjustment system Interpreted the psoriasis diagnosis and treatment guidelines and continued the psoriasis dandelion action; 3. Organized the compilation of the first edition of the "Chinese Children's Psoriasis Diagnosis and Treatment Guidelines", which has been revised in the Chinese Journal of Dermatology; 4. New licensing 2 outstanding psoriasis special disease demonstration outpatient units, 10 psoriasis special disease demonstration outpatient units, 31 psoriasis special disease outpatient units, and psoriasis special disease (demonstration) outpatient units totaling more than 280; 5 , Successfully held the 4th China Psoriasis Conference and the 2nd Boao Medical Forum Dermatology Biological Therapy Symposium, with a total of more than 500 participants offline; 6. World Psoriasis Day was launched nationwide on the same day The online and offline public welfare clinics provided free consultations for more than 8,000 psoriasis patients across the country; 7. In addition, in 2020, a total of 430,000 psoriasis patients were diagnosed and treated in the national psoriasis clinics; published psoriasis 189 papers related to disease, including 75 SCI papers; editor and author of 36 psoriasis-related monographs/person-time; psoriasis-related research results won 6 provincial and ministerial awards; carried out psoriasis dandelion action/patient education more than 500 The field benefited 730,000 people; the editor-in-chief published 1 guide/consensus related to psoriasis; obtained 14 national invention patents. Professor Zhang Xuejun also deployed the work plan of the Psoriasis Special Committee in 2021, and pointed out that the following 10 areas need to be focused on: 1. Continue to hold the Fifth China Psoriasis Conference; 2. Recruit psoriasis nationwide Patients participate in the psoriasis questionnaire survey and complete the epidemiological survey of GPA psoriasis patients; 3. Expand the number of psoriasis clinics nationwide, and plan to reach 330-350 in total; 4. Promote the "Psoriasis" together with GPA activities, etc. Popularization and clinical application of the popular science book "Interpretation of Psoriasis"; application of the popular science book of "Interpretation of Psoriasis" for the 2021 Chinese Preventive Medicine Association Science Popularization Award; 5. Initiation of the compilation of the new version of "Chinese Psoriasis Diagnosis and Treatment Guidelines"; 6. Compilation of "Consensus of Experts on Biological Treatment of Diseases"; 7. Expand the Psoriasis Group of Provincial Medical Associations; 8. Promote the inclusion of psoriasis in chronic disease management; 9. Further integrate with the International Psoriasis Association (IPC); 10. Hold The first Boao Innovative Medicine Forum-Dermatology Special Session. Professor Zhang Xuejun concluded and pointed out that it is expected that the Psoriasis Committee of the Chinese Medical Association Dermatology and Venereology Branch will continue to steadily advance the work in 2021 with the joint efforts of everyone, and make greater contributions to the development of my country's psoriasis prevention and treatment cause.
Professor Zhang Xuejun
Professor Chunlei Zhang
The Psoriasis Professional Committee has maintained good communication and exchanges since it joined the International Psoriasis Association in 2016. The International Psoriasis Society (IPC) strategic plan and related academic activities were introduced in 2016. The IPC strategic goals 1. Improve effective treatment methods, timely diagnosis and best care and nursing; 2. Lead the research on individualized treatment plans for patients; 3. :. Expand the knowledge of medical staff, and provide better diagnosis and treatment to patients with psoriasis through the dissemination of high-quality regional related education; 4. Establish a regional organization that supports the IPC strategic plan and solve local medical services; 5. Generate enough The budget and the use of advanced communication technology to implement the strategic plan. Professor Min Zheng also reviewed the 2020 International Psoriasis Association academic activities and the 2021 SID academic conference.
Professor Min Zheng
In recent years, with the establishment of special disease clinics, research centers, GPA China Committee, the publication of "Psoriasis Interpretation" and the successful development of dandelion popular science action, my country The psoriasis popular science education system has been basically established. Professor Shi Yuling, deputy chairman of the Psoriasis Professional Committee, systematically introduced the background and importance of the establishment of the disease science education system; summarized the effectiveness of the special committee in the construction of the science education system in recent years. The Dandelion Action is a psoriasis in the past six years. The popular science and health education public welfare activities that have been carried out in disease science education have carried out a total of hundreds of offline and online tour lectures, covering more than 500 experts and more than 100,000 patients, affecting millions of patients. In particular, hundreds of psoriasis experts and thousands of psoriasis patients face-to-face free consultation activities, which have had a good social impact. The establishment of the psoriasis popular science education system has achieved remarkable results, affecting doctors, patients and all sectors of society. The popular science education system is based on the dandelion psoriasis popular science education activities, with the popular science works of "Interpretation of Psoriasis" as the carrier, benefiting hundreds of Thousands of psoriasis patients and numerous primary dermatologists ultimately benefited the patients.
Professor Yuling Shi
Professor Sun Liangdan, chairman of the Psoriasis Research Center, gave a detailed report on the work of the 2021 GPA plan. Firstly, he summarized the successful implementation of 32 GPA series activities in 2020. The monitoring points are divided into six areas in the south, east and northwest of the country. Each area is mainly in charge of a monitoring point in the region; secondly, the use of the system and data quality control are introduced again; finally, Professor Sun Liangdan introduced the China Psoriasis Surveillance Project (CGPA) The goals for the next 3-5 years are planned, including goals, specific clinical data collection tasks, a series of academic activities, advancement of academic exchanges, and the further optimization of basic research and clinical diagnosis and treatment. At the same time, it is expected that in the next 10 years , Can establish a large-scale cohort of 300-500,000 people with psoriasis; continue to promote the better development of GPA in China.
Professor Sun Liangdan
Professor Wang Zaixing, director of the Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, reported on the preparatory work for the Fifth China Psoriasis Conference, including conference notice, conference promotion, and schedule As well as corporate investment promotion, the conference is scheduled to be held in Hefei from October 28th to 30th, 2021. It is planned to open a number of basic research, clinical diagnosis and treatment and new progress special sessions, which will be carried out in a combined online and offline manner. The online platform will be further improved, and the influence of the China Psoriasis Conference will be increased, and the online live broadcast platform of the China Psoriasis Conference will be built. Subsequently, we reviewed the achievements of the previous psoriasis conferences, and finally invited online and offline experts to meet at the Fifth China Psoriasis Conference in Hefei in 2021 to jointly promote basic scientific research and clinical prevention, diagnosis and treatment of psoriasis in my country. Contribute to development.
Professor Wang Zaixing
In this working conference, Professor Lu Qianjin, chairman of the Chinese Medical Association Dermatology Branch, was also invited to attend the meeting. Professor Lu first thanked the Psoriasis Committee The kind invitation fully affirmed the work done by the Psoriasis Committee under the leadership of Professor Zhang Xuejun for over a year, and pointed out that the basic research and prevention level of psoriasis in China has been improved year by year under the guidance of the Psoriasis Committee; Next, the Department of Dermatology and Venereology of the Chinese Medical Association will report on the 2020 work and the work arrangements for 2021. In 2020, the Department of Dermatology and Venereology of the Chinese Medical Association will prepare dermatology-related protection and control in the critical stage of epidemic prevention and control. Diagnosis and treatment standards, online free consultation, commendation of advanced anti-epidemic personnel and collectives, Hangzhou annual meeting, and the fifth academic annual meeting of experimental dermatology have been carried out smoothly; in 2021, the Chinese Medical Association Dermatology and Venereology Branch will gradually advance Big data + artificial intelligence, empower the management of chronic skin diseases, organize epidemiological surveys of important skin diseases (SLE, psoriasis), obtain data on Chinese skin disease patients, organize real-world research, guide clinical medication, and continue Strengthen clinical communication, further improve the level of diagnosis and treatment, continue to strengthen scientific research training, further improve the level of scientific research, and actively prepare for the 27th National Dermatology Annual Conference and the 6th Experimental Dermatology Annual Conference. Finally, Professor Lu hopes that my country's psoriasis prevention and control work will take a step forward and lead the world. I would like to express my heartfelt gratitude to the colleagues of the Psoriasis Committee for their support to the work of the society.
Professor Lu Qianjin
The successful convening of this meeting is inseparable from the support of the enterprise. This meeting is the first time that the national enterprise Wanbang Pharmaceutical has entered the field of psoriasis. In the satellite conference, I am honored to invite Professor Ding Yangfeng from Shanghai Dermatology Hospital as a speaker to give a presentation on the topic-the interpretation of the Phase III clinical study of Pi Xing Zhan Ji-Handa Yuan Ⓡ. Handa was approved by the State Food and Drug Administration in December 2020. It is the only adalimumab biosimilar produced by the China-Europe dual GMP certified production base, and it is also the only adalimumab with Phase III clinical data of plaque psoriasis among the domestically marketed adalimumab biosimilars. HandayuanⓇ uses the original adalimumab as the reference drug, and has carried out a number of head-to-head comparison studies with the original research adalimumab. The research results prove that HandayuanⓇ is comparable to the original research in terms of quality, safety and effectiveness. The drugs are highly similar.
Professor Ding Yangfeng
Professor Zhang Furen, vice chairman of the Chinese Medical Association Dermatology Branch, introduced the content of the second prize of the National Natural Science Award 2020 "Immune Genetic Mechanism of Leprosy Hazard" Professor Zhang first pointed out that psoriasis and leprosy are genetically related, and genetic studies have shown that leprosy and psoriasis are susceptible to gene mutations that protect each other; leprosy is a disabling and disfiguring infectious disease. Two key scientific issues are put forward: how to identify high-risk individuals among close contacts and clarify their pathogenesis, and how to determine which individuals will develop DHS and clarify its pathogenesis. The project carried out epidemiology, molecular genetics, immune mechanism analysis and pharmacogenomics research. Realize the precise chemical prevention and precise treatment of leprosy and reduce the incidence of adverse reactions. The project results are recognized by international and domestic colleagues, and at the same time produce important international influence. Part of the results developed the HLA-B*13:01 screening kit, and was approved for 6 international invention patents (US, New Zealand, Japan, Korea, Europe, and India) and national invention patents; the data generated by the project was collected from Harvard University, Stanford University, etc. To share with domestic and foreign counterparts. In the end, Professor Zhang Furen also fully affirmed the work of the special committee in 2029 and the future development direction; he hopes that the psoriasis transfer to the special committee will make greater achievements.
Professor Zhang Furen
Professor Cui Yong, chairman of the Dermatology Committee of the National Telemedicine and Internet Medical Center, based on the construction of the psoriasis prevention and control system based on big data-mechanism research, The topic of clinical diagnosis and curative effect evaluation, introduces the win-lose and application scenarios of big data, and points out that skin diseases are a natural "big database", psoriasis is a major and chronic disease that has been neglected, and the ideal "big database" for psoriasis should be Real-world research including "holographic data" such as genes, phenotypes, and treatment dynamics. The psoriasis database has application prospects in mechanism research, clinical diagnosis, and efficacy evaluation. It is also the current and future precision medicine research and artificial intelligence of psoriasis. The basis for diagnosis and decision-making. Introduced the established skin imaging resource database of the Chinese population that includes the collection and classification of more than 300,000 skin multi-dimensional imaging resources: big data management platform and chronic psoriasis management AI to help grassroots dermatologists assist in the disease Diagnosis; also pointed out the current bottleneck of AI in psoriasis. Finally, it introduces the current status of psoriasis drug treatment, the new psoriasis big data collection platform: special disease clinic and GPA; and puts forward the problems that still need to be solved at this stage. Expect big data to provide unlimited potential for the psoriasis prevention and control system.
Professor Cui Yong
Professor Zhang Xibao, consultant of the Psoriasis Committee, interpreted the "Guidelines for the Diagnosis and Treatment of Psoriasis in Children in China" compiled in 2020, and pointed out that the society should pay attention to children. Special groups, protect vulnerable groups, standardize the diagnosis and treatment of psoriasis in children, and the guidelines focus on the safety of treatment. At present, the treatment drugs and treatment methods for pediatric patients are limited, and the establishment of safe, effective, and standardized documents for the diagnosis and treatment of psoriasis suitable for children is an urgent need for clinical dermatologists. Professor Zhang Xibao gave a systematic introduction from the composition of the editorial committee, the determination of the writing method and content, the writing methodology, the structure, the writing process, the background, the formulation basis, the current status of diagnosis and treatment, and the writing content. The "Guidelines for the Diagnosis and Treatment of Psoriasis in Children in China" was released in Hefei, Anhui in October 2020, and has been revised in the Chinese Journal of Dermatology.
Professor Zhang Xibao
The last speaker of this working conference, Professor Li Yuzhen, deputy chairman of the Psoriasis Committee, introduced the "Expert Consensus on Methotrexate Treatment of Psoriasis "Interpretation of the 2021 edition, Professor Li pointed out that methotrexate (MTX) is currently one of the most effective traditional drugs for the treatment of psoriasis. It is effective for moderate to severe plaque psoriasis, erythroderma-type psoriasis, and severe psoriasis. There are indications for the treatment of blister psoriasis and arthropathy-type psoriasis; the mechanism and clinical application of MTX are introduced in detail, the contraindications of the application in psoriasis, the general evaluation before medication, and the routine laboratory examination , Dosage and methods of administration, medication for special populations, side effects and monitoring, drug interactions, MTX overdose and treatment, etc., introduced this edition of the Expert Consensus. At present, the consensus has been submitted to the Chinese Journal of Dermatology for review.
Professor Li Yuzhen
At the end of the meeting, all the people present took a group photo.
Meeting photo
Writer: Zhu Zhengwei
